Wang, F.; Lin, M.; Liu, Y.; Wang, H.; Li, B.; Yang, T.; Li, W.
Dual-Targeting CSC Therapy: Acid-Responsive Cisplatin/CaCO3@siRNA Nanoplatform Overcomes HCC Chemoresistance. Pharmaceuticals 2026, 19, 22.
https://doi.org/10.3390/ph19010022
AMA Style
Wang F, Lin M, Liu Y, Wang H, Li B, Yang T, Li W.
Dual-Targeting CSC Therapy: Acid-Responsive Cisplatin/CaCO3@siRNA Nanoplatform Overcomes HCC Chemoresistance. Pharmaceuticals. 2026; 19(1):22.
https://doi.org/10.3390/ph19010022
Chicago/Turabian Style
Wang, Fei, Ming Lin, Yong Liu, Han Wang, Bin Li, Tan Yang, and Weijie Li.
2026. "Dual-Targeting CSC Therapy: Acid-Responsive Cisplatin/CaCO3@siRNA Nanoplatform Overcomes HCC Chemoresistance" Pharmaceuticals 19, no. 1: 22.
https://doi.org/10.3390/ph19010022
APA Style
Wang, F., Lin, M., Liu, Y., Wang, H., Li, B., Yang, T., & Li, W.
(2026). Dual-Targeting CSC Therapy: Acid-Responsive Cisplatin/CaCO3@siRNA Nanoplatform Overcomes HCC Chemoresistance. Pharmaceuticals, 19(1), 22.
https://doi.org/10.3390/ph19010022